rs1076560
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000795.4(DRD2):c.811-83G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 1,458,296 control chromosomes in the GnomAD database, including 25,456 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2565 hom., cov: 32)
Exomes 𝑓: 0.18 ( 22891 hom. )
Consequence
DRD2
NM_000795.4 intron
NM_000795.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.298
Genes affected
DRD2 (HGNC:3023): (dopamine receptor D2) This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 11-113412966-C-A is Benign according to our data. Variant chr11-113412966-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 375655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRD2 | NM_000795.4 | c.811-83G>T | intron_variant | ENST00000362072.8 | NP_000786.1 | |||
DRD2 | NM_016574.4 | c.724-83G>T | intron_variant | NP_057658.2 | ||||
DRD2 | XM_017017296.3 | c.811-83G>T | intron_variant | XP_016872785.1 | ||||
DRD2 | XM_047426511.1 | c.724-83G>T | intron_variant | XP_047282467.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD2 | ENST00000362072.8 | c.811-83G>T | intron_variant | 1 | NM_000795.4 | ENSP00000354859 | P4 |
Frequencies
GnomAD3 genomes AF: 0.165 AC: 25135AN: 151954Hom.: 2556 Cov.: 32
GnomAD3 genomes
AF:
AC:
25135
AN:
151954
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.175 AC: 228600AN: 1306224Hom.: 22891 AF XY: 0.177 AC XY: 114338AN XY: 647428
GnomAD4 exome
AF:
AC:
228600
AN:
1306224
Hom.:
AF XY:
AC XY:
114338
AN XY:
647428
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.165 AC: 25163AN: 152072Hom.: 2565 Cov.: 32 AF XY: 0.173 AC XY: 12842AN XY: 74328
GnomAD4 genome
AF:
AC:
25163
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
12842
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1101
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | This variant is associated with the following publications: (PMID: 17196743, 22569179, 18077373, 21150907, 26347318, 19940176, 18829695) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Dystonic disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at